Top 11 Small Cap Stocks to Buy with Biggest Upside Potential
On April 24, Jill Carey Hall, BofA Securities head of U.S. small/mid-cap strategy, appeared on 'Closing Bell' to talk about the impact of tariffs on small caps.
Centessa Pharmaceuticals Plc (CNTA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 2,960,029 | $42,565,217 | -2% | 2.42% |
| 2. | Wildcat Capital Management Leonard A. Potter | 281,859 | $4,053,132 | 2.16% | |
| 3. | SilverArc Capital Devesh Gandhi | 232,758 | $3,347,060 | -62% | 0.68% |
| 4. | Renaissance Technologies Jim Simons | 178,000 | $2,559,640 | -1% | 0% |
| 5. | Walleye Capital Will England | 82,199 | $1,182,022 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.63 | 10,000 | Officer, Director | 38,000 | 2022-06-24 | Filing | |
| $9.74 | 5,000 | Officer, Director | 28,000 | 2022-02-02 | Filing | |
| $9.05 | 27,500 | Officer | 27,500 | 2022-01-28 | Filing | |
| $12.82 | 796 | Director | 93,526 | 2021-12-02 | Filing | |
| $12.82 | 33,530 | Director | 3,936,970 | 2021-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.00 | 311 | Officer | 105,386 | 2025-05-01 | Filing | |
| $14.01 | 2,080 | Officer | 105,386 | 2025-04-28 | Filing | |
| $14.00 | 3,609 | Officer | 105,386 | 2025-04-25 | Filing | |
| $13.61 | 11,742 | Officer | 122,279 | 2025-04-25 | Filing | |
| $12.43 | 40,344 | Officer, Director | 221,017 | 2025-04-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,963,157 | $287,070,198 | 65.59% | |
| 2. | 9,681,818 | $139,224,543 | 4.67% | |
| 3. | 3,826,194 | $55,020,670 | 0% | |
| 4. | 2,890,816 | $41,569,934 | 5.67% | |
| 5. | 2,541,999 | $36,553,943 | 0.01% |
News See All
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
12 Best Growth Stocks Under $25 to Buy Now
Most experts agree that the AI wave is not over yet.
10 Small Cap Stocks with High Potential
As we transition from a tumultuous summer in the financial markets, characterized by rising expectations for interest rate cuts and the consequent impacts on stock and bond performances, investors are...
10 Best Biotech Stocks To Buy Under $20
The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.
Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Billionaire Hedge Funds
